Basit öğe kaydını göster

Tissue and Plasma Thioredoxin Reductase Expressions in Patients with Glioblastoma Multiforme

dc.contributor.authorHanimoglu, Hakan
dc.contributor.authorTanriverdi, Taner
dc.contributor.authorKacira, Tibet
dc.contributor.authorKucur, Mine
dc.contributor.authorCanbaz, Bulent
dc.contributor.authorKemerdere, Rahsan
dc.date.accessioned2021-03-03T19:18:50Z
dc.date.available2021-03-03T19:18:50Z
dc.date.issued2013
dc.identifier.citationKemerdere R., Kacira T., Hanimoglu H., Kucur M., Tanriverdi T., Canbaz B., "Tissue and Plasma Thioredoxin Reductase Expressions in Patients with Glioblastoma Multiforme", JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, cilt.74, sa.4, ss.234-238, 2013
dc.identifier.issn2193-6315
dc.identifier.otherav_53dd9dba-bb40-444c-9739-fc6c6087d4a1
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/59435
dc.identifier.urihttps://doi.org/10.1055/s-0032-1333422
dc.description.abstractBackground and Study Aims Thioredoxin reductase (TrxR) is a redox protein that is considered to play a role in tumor progression. The purpose of this study was to assess the expression of TrxR in blood and tumor samples of glioblastoma multiforme (GBM) patients.
dc.language.isoeng
dc.subjectCerrahi Tıp Bilimleri
dc.subjectTıp
dc.subjectNöroloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleTissue and Plasma Thioredoxin Reductase Expressions in Patients with Glioblastoma Multiforme
dc.typeMakale
dc.relation.journalJOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume74
dc.identifier.issue4
dc.identifier.startpage234
dc.identifier.endpage238
dc.contributor.firstauthorID89795


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster